Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income and Growth VCT 2 Regulatory News (MIG2)

Share Price Information for Maven Income and Growth VCT 2 (MIG2)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
MIG2 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income and Growth VCT 2 Share Chart

Interim Management Statement

9 Jun 2010 11:40

RNS Number : 3164N
Maven Income and Growth VCT 2 PLC
09 June 2010
 



Maven Income and Growth VCT 2 PLC (the Company)

 

Interim Management Statement - Quarter ended 30 April 2010

 

This Interim Management Statement, for the quarter ended 30 April 2010, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 May 2010 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1. Financial highlights

 

·; Net Asset Value (NAV)* of 53.9p at 30 April 2010; compared to 53.5p on 31 January 2010;

·; 1,943,442 Ordinary Shares issued under Linked VCT Offer;

·; 215,653 Ordinary Shares bought back for cancellation; and

·; final dividend of 1.5p per Ordinary Share to be paid on 25 June 2010.

 

\* The NAV is unaudited and reflects the closing bid price of quoted securities at 30 April 2010. Unlisted companies are normally valued on a six-monthly basis; the NAV incorporates the Directors' valuation of unlisted investments as at 31 January 2010, adjusted for subsequent events where appropriate.

 

2. Investments and disposals

 

One new unlisted investment was completed during the quarter ended 30 April 2010 and, including the provision of support to existing portfolio companies, a total of £304,000 was invested. In the same period, the disposal of two unlisted holdings and two AIM quoted investments generated aggregate proceeds of £388,000 against a cost of £462,000.

 

3. Recent developments

Between 30 April 2010 and the date of this statement, additional funding totalling £51,000 was provided to three unlisted investments.

 

During the same post quarter-end period: £2,000 was received in respect of deferred consideration from the previous disposal of an unlisted investment; the partial disposal of an AIM quoted investment generated proceeds of £67,000 against a cost of £20,000; and proceeds of £500,000 were received on the redemption of UK treasury stock.

 

4. VAT recovery

The Company has received £217,019 from Aberdeen Asset Management PLC in respect of the recovery of VAT charged on investment management fees between 1 October 2005 and 1 October 2008. As these proceeds were not received until 8 June 2010, this amount had not been accrued as at 30 April 2010 but would have the effect of increasing the NAV per share by 0.9p.

 

Other than described above and the impact of movements related to the prices of shares in quoted securities, the Board is not aware of any material events during the period from 1 February 2010 to 30 April 2010, or in the period from 1 May 2010 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

9 June 2010

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMGGVGLKGGZM
Date   Source Headline
15th Nov 20183:13 pmRNSDirectorate Change
15th Nov 20183:01 pmRNSMerger Update: Approval of Scheme
15th Nov 201812:09 pmRNSResult of Second General Meeting
15th Nov 20187:30 amRNSSuspension- Maven Income and Growth VCT 2 PLC
15th Nov 20187:30 amRNSSuspension of Trading
1st Nov 201812:23 pmRNSResult of General Meeting
8th Oct 20187:00 amRNSStatement re Proposed Merger
13th Sep 20186:16 pmRNSPossible Merger
12th Sep 20181:45 pmRNSNet Asset Value(s)
21st Jun 20183:33 pmRNSTransaction in Own Shares
13th Jun 201812:46 pmRNSNet Asset Value(s)
13th Jun 201812:45 pmRNSResult of AGM
17th May 20184:30 pmRNSDividend Declaration
11th May 20184:05 pmRNSAnnual Financial Report
16th Mar 20184:52 pmRNSNet Asset Value(s)
22nd Dec 201710:47 amRNSDividend Declaration
8th Dec 201712:44 pmRNSNet Asset Value(s)
19th Oct 20174:52 pmRNSTransaction in Own Shares
5th Oct 20174:51 pmRNSTransaction in Own Shares
29th Sep 20177:00 amRNSHalf-year Report
18th Sep 20173:39 pmRNSNet Asset Value(s)
17th Aug 20174:09 pmRNSDividend Declaration
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC
14th Jun 20171:56 pmRNSNet Asset Value and Final Dividend
14th Jun 20171:43 pmRNSResult of AGM
12th May 20174:32 pmRNSAnnual Financial Report
6th Apr 20173:59 pmRNSNet Asset Value and Proposed Final Dividend
20th Jan 20174:47 pmRNSTransaction in Own Shares
8th Dec 201612:09 pmRNSNet Asset Value(s)
23rd Sep 20169:55 amRNSHalf-year Report
15th Sep 20163:38 pmRNSDirector/PDMR Shareholding
13th Sep 20162:52 pmRNSStatement re NAV & Dividend
6th Jul 20164:43 pmRNSTransaction in Own Shares
15th Jun 201612:29 pmRNSNet Asset Value(s)
15th Jun 201612:27 pmRNSResult of AGM
6th May 20163:56 pmRNSAnnual Financial Report
11th Apr 20164:56 pmRNSTransaction in Own Shares
30th Mar 20162:45 pmRNSNet Asset Value and Proposed Final Dividend
10th Feb 20163:39 pmRNSForm 8.3 - Tangent Communications PLC
9th Dec 20154:17 pmRNSPortfolio Update and Unaudited Net Asset Value
30th Sep 201512:33 pmRNSHalf Yearly Report
24th Sep 20151:36 pmRNSStatement re NAV and Dividend Payments
16th Sep 20152:28 pmRNSDirectorate Change
4th Sep 201510:50 amRNSPortfolio Update
24th Aug 20153:36 pmRNSStatement re Dividend Investment Scheme
2nd Jul 20152:36 pmRNSDirector/PDMR Shareholding
26th Jun 201512:40 pmRNSIssue of Equity
26th Jun 20159:38 amRNSNet Asset Value(s)
24th Jun 20154:42 pmRNSDirector/PDMR Shareholding
17th Jun 20151:08 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.